03320 News
MSCI China Index Changes to Take Effect After Market Close on November 24; New Additions Include GANFENGLITHIUM and GF SEC
CLSA Increases Price Targets for SINOPHARM and SH PHARMA, Lowers CHINARES PHARMA's Target Price to HKD 5.6
CHINARES PHARMA Reports Interim Net Profit of RMB 2.077 Billion, a 20.3% Decrease; Interim Dividend Per Share at RMB 0.072
03320 Events

No data
03320 Monitor News

No data
03320 Earnings Analysis
